目次
第1章：唾液採取＆診断市場 エグゼクティブサマリー
1.1. グローバル市場規模および予測（2022年～2032年）
1.2. 地域別概観
1.3. セグメント別分析
1.3.1. 収集場所別
1.3.2. 用途別
1.3.3. エンドユース別
1.4. 主要な市場動向
1.5. 不況の影響分析
1.6. アナリストの推奨
________________________________________
第2章：市場定義と調査の前提条件
2.1. 調査目的
2.2. 市場定義
2.3. 調査の前提条件
2.3.1. 対象および除外基準
2.3.2. 制限
2.3.3. 供給サイド分析
2.3.4. 需要サイド分析
2.4. 推定方法
2.5. 調査対象年
________________________________________
第3章：市場力学
3.1. 市場推進要因
3.1.1. 非侵襲的診断処置の採用増加
3.1.2. サンプル採取における技術的進歩
3.1.3. 唾液ベース診断の用途拡大
3.2. 市場の課題
3.2.1. 新興市場における規制障壁
3.2.2. サンプルの安定性と完全性における課題
3.3. 市場機会
3.3.1. マルチプレックス検査能力の成長
3.3.2. 研究開発への投資の増加
________________________________________
第4章：業界分析
4.1. ポーターのファイブフォース分析
4.2. PESTEL分析
4.3. 診断における破壊的トレンド
4.4. 主な投資機会
4.5. 専門家の推奨
________________________________________
第5章：採取部位別の世界市場規模および予測（2022年～2032年
5.1. 耳下腺採取
5.2. 顎下腺/舌下腺採取
5.3. その他
________________________________________
第6章：用途別世界市場規模・予測（2022年～2032年）
6.1. 疾患診断
6.2. 法医学用途
6.3. 研究
________________________________________
第7章：エンドユース別世界市場規模・予測（2022年～2032年）
7.1. 診断ラボ
7.2. 製薬・バイオテクノロジー企業
7.3. 研究機関
7.4. 歯科
________________________________________
第8章：地域別分析（2022年～2032年）
8.1. 北米
8.2. ヨーロッパ
8.3. アジア太平洋
8.4. ラテンアメリカ
8.5. 中東およびアフリカ
________________________________________
第9章：競合情報
9.1. 主要企業のSWOT分析
9.1.1. Thermo Fisher Scientific, Inc.
9.1.2. Neogen Corporation
9.1.3. Abbott
9.2. 戦略的展開
9.3. 市場シェア分析
________________________________________
第10章：調査プロセス
10.1. データ収集の処置
10.2. 市場推定の方法
10.3. 検証プロセス

The Global Saliva Collection and Diagnostics Market is poised for significant growth, with an estimated valuation of USD 0.78 Billion in 2023, projected to reach USD 1.18 Billion by 2032, growing at a CAGR of 4.7% during the forecast period.

This surge is attributed to rising advancements in non-invasive diagnostic technologies, growing awareness about saliva-based testing, and innovations in sample collection devices.

The COVID-19 pandemic acted as a key accelerator, highlighting saliva's potential as a viable sample type for diagnostic applications, including infectious disease testing. The non-invasive nature of saliva collection methods, coupled with innovations like the SpeciMAX Stabilized Saliva Collection Kit, has further propelled market adoption. Moreover, the expansion of saliva-based diagnostics beyond COVID-19 into areas such as hormonal monitoring, stress analysis, and chronic disease detection underpins the increasing preference for this sample type over traditional blood tests.

Significant advancements in multiplex testing capabilities are streamlining the diagnostic process, enabling the simultaneous detection of multiple biomarkers from a single saliva sample. Applications in fields such as occupational health, sports medicine, and oncology are further bolstering the market's prospects.

Regionally, North America dominated in 2024 with a revenue share of 48.71%, driven by an increase in infectious disease cases and advancements in testing technology. In Europe, the market benefits from a robust healthcare infrastructure and rising regional players introducing innovative solutions. Meanwhile, the Asia Pacific region is witnessing the fastest growth, driven by increasing adoption of non-invasive testing methods.
________________________________________
Major market players included in this report are:
• Thermo Fisher Scientific, Inc.
• Neogen Corporation
• Abbott
• Sarstedt AG & Co.KG
• Autogen, Inc.
• Oasis Diagnostics
• Porex
• Salimetrics, LLC
• Takara Bio, Inc.
• Arcis Bio
• Orasure Technologies
• Nusantics Group
• Mark Microbiotech
• Bio Farma
• Salignostics
________________________________________
The detailed segments and sub-segments of the market are explained below:
By Site of Collection:
• Parotid Gland Collection
• Submandibular/Sublingual Gland Collection
• Others

By Application:
• Disease Diagnostics
• Forensic Applications
• Research

By End-Use:
• Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Dentistry

By Region:
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o Saudi Arabia
o South Africa
o UAE
o Kuwait

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecasts for 10 years (2022–2032).
• Annualized revenues and regional-level analysis for each market segment.
• Competitive landscape analysis with company profiles of major players.
• Strategic insights on emerging market trends and opportunities.

Table of Contents
Chapter 1: Global Saliva Collection and Diagnostics Market Executive Summary
1.1. Global Market Size & Forecast (2022–2032)
1.2. Regional Overview
1.3. Segmental Analysis
1.3.1. By Site of Collection
1.3.2. By Application
1.3.3. By End-Use
1.4. Key Market Trends
1.5. Recession Impact Analysis
1.6. Analyst Recommendations
________________________________________
Chapter 2: Market Definition and Research Assumptions
2.1. Research Objectives
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion Criteria
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.4. Demand-Side Analysis
2.4. Estimation Methodology
2.5. Years Considered for the Study
________________________________________
Chapter 3: Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption of Non-Invasive Diagnostic Techniques
3.1.2. Technological Advancements in Sample Collection
3.1.3. Expanding Applications of Saliva-Based Diagnostics
3.2. Market Challenges
3.2.1. Regulatory Barriers in Emerging Markets
3.2.2. Challenges in Sample Stability and Integrity
3.3. Market Opportunities
3.3.1. Growth in Multiplex Testing Capabilities
3.3.2. Rising Investment in R&D
________________________________________
Chapter 4: Industry Analysis
4.1. Porter’s Five Forces Analysis
4.2. PESTEL Analysis
4.3. Disruptive Trends in Diagnostics
4.4. Key Investment Opportunities
4.5. Expert Recommendations
________________________________________
Chapter 5: Global Market Size and Forecast by Site of Collection (2022–2032)
5.1. Parotid Gland Collection
5.2. Submandibular/Sublingual Gland Collection
5.3. Others
________________________________________
Chapter 6: Global Market Size and Forecast by Application (2022–2032)
6.1. Disease Diagnostics
6.2. Forensic Applications
6.3. Research
________________________________________
Chapter 7: Global Market Size and Forecast by End-Use (2022–2032)
7.1. Diagnostic Laboratories
7.2. Pharmaceutical & Biotechnology Companies
7.3. Research Institutes
7.4. Dentistry
________________________________________
Chapter 8: Regional Analysis (2022–2032)
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
________________________________________
Chapter 9: Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Thermo Fisher Scientific, Inc.
9.1.2. Neogen Corporation
9.1.3. Abbott
9.2. Strategic Developments
9.3. Market Share Analysis
________________________________________
Chapter 10: Research Process
10.1. Data Collection Techniques
10.2. Market Estimation Methods
10.3. Validation Process

❖ 掲載企業 ❖

Thermo Fisher Scientific, Inc.、Neogen Corporation、Abbott、Sarstedt AG & Co.KG、Autogen, Inc.、Oasis Diagnostics、Porex、Salimetrics, LLC、Takara Bio, Inc.、Arcis Bio、Orasure Technologies、Nusantics Group、Mark Microbiotech、Bio Farma、Salignosticsなど

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer